Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;1:CD001216.
   Google Scholar
• Wieten E, Schreuders EH, Grobbee EJ, et al. Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis. Gut Published Online First: 22 June 2018. doi: 10.1136/gutjnl-2017-315340.
   Google Scholar
• Launois R, Le Moine JG, Uzzan B, et al. Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening. Eur J Gastroenterol Hepatol. 2014;26:978–989.
   PubMedGoogle Scholar
• Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60:609–622.
   PubMed Web of Science ®Google Scholar
• Giorgi Rossi P, Vicentini M, Sacchettini C, et al. Impact of screening program on incidence of colorectal cancer: a cohort study in Italy. Am J Gastroenterol. 2015;110:1359–1366.
   PubMed Web of Science ®Google Scholar
• Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649.
   PubMed Web of Science ®Google Scholar
• Moss S, Mathews C, Day TJ, et al. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Gut. 2017;66:1631–1644.
   PubMed Web of Science ®Google Scholar
• Santare D, Kojalo I, Huttunen T, et al. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use. Eur J Gastroenterol Hepatol. 2015;27:536–543.
   PubMed Web of Science ®Google Scholar
• Ertem FU, Ladabaum U, Mehrotra A, et al. Incidence of interval colorectal cancer attributable to an endoscopist in clinical practice. Gastrointestinal Endoscopy, 2018-10-01, Volume 88, Issue 4, Pages 705-711.e1.
   Google Scholar
• Hilsden RJ, Dube C, Heitman SJ, et al. The association of colonoscopy quality indicators with the detection of screen-relevant lesions, adverse events, and postcolonoscopy cancers in an asymptomatic Canadian colorectal cancer screening population. Gastrointest Endosc. 2015;82:887–894.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795–1803.
   PubMed Web of Science ®Google Scholar
• Tinmouth J, Kennedy EB, Baron D, et al. Colonoscopy quality assurance in Ontario: systematic review and clinical practice guideline. Can J Gastroenterol Hepatol. 2014;28:251–274.
   PubMed Web of Science ®Google Scholar
• Shaukat A, Rector TS, Church TR, et al. Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology. 2015;149:952–957.
   PubMed Web of Science ®Google Scholar
• Baxter NN, Sutradhar R, Forbes SS, et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011;140:65–72.
   PubMed Web of Science ®Google Scholar
• Tepes B, Bracko M, Novak Mlakar D, et al. Results of the FIT-based National Colorectal Cancer Screening Program in Slovenia. J Clin Gastroenterol. 2017;51:e52–e59.
   PubMed Web of Science ®Google Scholar
• Zorzi M, Senore C, Da Re F, et al. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut. 2015;64:1389–1396.
   PubMed Web of Science ®Google Scholar
• Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Wieszczy P, Rupinski M, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98–105.
   PubMed Web of Science ®Google Scholar
• Murchie B, Tandon K, Zackria S, et al. Can polyp detection rate be used prospectively as a marker of adenoma detection rate? Surg Endosc. 2018;32:1141–1148.
   PubMed Web of Science ®Google Scholar
• Francis DL, Rodriguez-Correa DT, Buchner A, et al. Application of a conversion factor to estimate the adenoma detection rate from the polyp detection rate. Gastrointest Endosc. 2011;73:493–497.
   PubMed Web of Science ®Google Scholar
• Niv Y. Polyp detection rate may predict adenoma detection rate: a meta-analysis. Eur J Gastroenterol Hepatol. 2018;30:247–251.
   PubMed Web of Science ®Google Scholar
• Schramm C, Scheller I, Franklin J, et al. Predicting ADR from PDR and individual adenoma-to-polyp-detection-rate ratio for screening and surveillance colonoscopies: a new approach to quality assessment. United European Gastroenterol J. 2017;5:742–749.
   PubMed Web of Science ®Google Scholar
• Njor SH, Friis-Hansen L, Andersen B, et al. Three years of colorectal cancer screening in Denmark. Cancer Epidemiol. 2018;57:39–44.
   PubMed Web of Science ®Google Scholar
• The Danish Pathology Bank. [cited 2018 May 15]. Available from: http://www.patobank.dk/.
   Google Scholar
• Erichsen R, Lash TL, Hamilton-Dutoit SJ, et al. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol. 2010;2:51–56.
   PubMedGoogle Scholar
• Civil Registration System. [cited 2018 Nov 14]. Available from: https://www.cpr.dk/cpr-systemet/.
   Google Scholar
• Atia MA, Ramirez FC, Gurudu SR. Quality monitoring in colonoscopy: time to act. World J Gastrointest Endosc. 2015;7:328–335.
   PubMed Web of Science ®Google Scholar
• Pullens HJ, Siersema PD. Quality indicators for colonoscopy: current insights and caveats. Wjge. 2014;6:571–583.
   Google Scholar
• Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81:31–53.
   PubMed Web of Science ®Google Scholar
• Chilton A, Rutter M, Roland V, et al. Quality Assurance Guidelines for Colonoscopy, NHS BCSP Publication No 6, February 2011, ISBN 978-1-84463-077-6. 2011; [cited 2017 Oct 23]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/427591/nhsbcsp06.pdf.
   Google Scholar
• Altman DG. Practical statistics for medical research. Publisher location: New York; Chapman and Hall/CRC; 1990.
   Google Scholar
• StataCorp. Stata statistical software: Release 15. College Station, TX: StataCorp LLC; 2017.
   Google Scholar
• Lee TJ, Rutter MD, Blanks RG, et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut. 2012;61:1050–1057.
   PubMed Web of Science ®Google Scholar